Prescription drug · UNAPPROVED DRUG OTHER
Phenazopyridine Hydrochloride (phenazopyridine) NDC 68071-2357
Phenazopyridine hydrochloride 100 mg/1 · Tablet · Oral · NuCare Pharmaceuticals,Inc.
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 68071-2357-2 | 68071235702 | 12 TABLET in 1 BOTTLE (68071-2357-2)Marketed from Mar 8, 2021 | |
| 68071-2357-4 | 68071235704 | 4 TABLET in 1 BOTTLE (68071-2357-4)Marketed from Mar 8, 2021 | |
| 68071-2357-8 | 68071235708 | 8 TABLET in 1 BOTTLE (68071-2357-8)Marketed from Mar 8, 2021 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Phenazopyridine Hydrochloride
- Generic name (nonproprietary)
- phenazopyridine
- Active ingredients
- Phenazopyridine hydrochloride — 100 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- NuCare Pharmaceuticals,Inc.
- Product type
- Prescription drug
- Marketing category
- Unapproved drug (other)
- Marketing start
- Listing expires
- Identifiers
- Product ID 68071-2357_4b34f7e8-fb23-1311-e063-6294a90a3a1cSPL ID 4b34f7e8-fb23-1311-e063-6294a90a3a1cSPL set ID bd0ae1dc-f170-eda6-e053-2995a90a6c9bRxCUI 1094107UNII 0EWG668W17UPC 0368071235784
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N468071235702followed by a unit qualifier and the quantityPackage 68071-2357-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Phenazopyridine HCl is indicated for the symptomatic relief of pain, burning, urgency, frequency, and other discomforts arising from irritation of the lower urinary tract mucosa caused by infection, trauma, surgery, endoscopic procedures, or the passage of sounds or catheters. The use of Phenazopyridine HCl for relief of symptoms should not delay definitive diagnosis and treatment of causative conditions. Because it provides only symptomatic relief, prompt appropriate treatment of the cause of pain must be instituted and Phenazopyridine HCl should be discontinued when symptoms are controlled. The analgesic action may reduce or eliminate the need for systemic analgesics …
Excerpt only. Read the full label for complete information.